FDA Approved: GABAPENTIN — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for gabapentin from Camber Pharmaceuticals, enabling the generic version to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Postherpetic Neuralgia

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

SUPPL AP for GABAPENTIN (GABAPENTIN)